Invesco Ltd. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 116 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$1,021,955
+4.2%
37,135
+28.5%
0.00%
Q2 2023$980,916
-71.3%
28,910
-69.6%
0.00%
-100.0%
Q1 2023$3,423,713
+0.4%
95,156
+24.4%
0.00%0.0%
Q4 2022$3,408,803
+614.6%
76,482
+350.5%
0.00%
Q3 2022$477,000
-11.5%
16,977
-15.0%
0.00%
Q2 2022$539,000
-12.5%
19,974
+10.2%
0.00%
Q1 2022$616,000
-92.3%
18,123
-91.3%
0.00%
-100.0%
Q4 2021$8,025,000
-72.2%
207,672
-61.1%
0.00%
-71.4%
Q3 2021$28,830,000
+100.3%
533,985
+24.1%
0.01%
+75.0%
Q2 2021$14,392,000
+168.2%
430,407
+65.2%
0.00%
+300.0%
Q1 2021$5,366,000
-32.3%
260,495
-51.3%
0.00%
-66.7%
Q3 2020$7,928,000
+8909.1%
534,584
+1257.0%
0.00%
Q4 2019$88,000
-1.1%
39,394
-6.2%
0.00%
Q3 2019$89,000
-23.9%
41,997
-3.8%
0.00%
Q2 2019$117,000
-47.3%
43,641
-3.3%
0.00%
Q1 2019$222,00045,1480.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2021
NameSharesValueWeighting ↓
Kynam Capital Management, LP 1,605,390$71,552,23210.98%
Octagon Capital Advisors LP 761,398$33,935,5095.28%
TSP Capital Management Group, LLC 269,895$12,029,2254.50%
Redmile Group, LLC 1,977,451$88,134,9913.60%
COMMODORE CAPITAL LP 495,823$22,0993.33%
Tri Locum Partners LP 176,109$7,849,0003.18%
ACUTA CAPITAL PARTNERS, LLC 115,000$5,125,5503.15%
Ikarian Capital, LLC 267,476$11,921,4062.88%
RTW INVESTMENTS, LP 3,084,215$137,463,4632.81%
Eversept Partners, LP 558,774$24,904,5572.18%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders